About EpiBone
EpiBone is a company based in Brooklyn (United States) founded in 2013 by Elisa Cimetta, Sarindr Bhumiratana, and Sidney Eisig.. EpiBone has raised $48.63 million across 10 funding rounds from investors including HHS, Hackensack Meridian Health and EMV Capital. EpiBone offers products and services including Bioreactor and Personalized Bone Products. EpiBone operates in a competitive market with competitors including ViaCyte, Capricor Therapeutics, Neurona Therapeutics, MiMedx Group and Ossio, among others.
- Headquarter Brooklyn, United States
- Founders Elisa Cimetta, Sarindr Bhumiratana, Sidney Eisig
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$48.63 M (USD)
in 10 rounds
-
Latest Funding Round
$4.29 M (USD), Series B
Sep 02, 2025
-
Investors
HHS
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EpiBone
EpiBone offers a comprehensive portfolio of products and services, including Bioreactor and Personalized Bone Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device that grows personalized bone from stem cells for healing.
Custom-grown bone and cartilage to replace damaged tissue.
Unlock access to complete
Unlock access to complete
Funding Insights of EpiBone
EpiBone has successfully raised a total of $48.63M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $4.29 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $4.3M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Series B - EpiBone | Valuation |
investors |
|
| Nov, 2024 | Amount | Series B - EpiBone | Valuation | Kendall Capital Partners | |
| Dec, 2022 | Amount | Series B - EpiBone | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EpiBone
EpiBone has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Hackensack Meridian Health and EMV Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are focused on health technology breakthroughs.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
B2B-tech focused VC firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EpiBone
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EpiBone
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epibone Comparisons
Competitors of EpiBone
EpiBone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ViaCyte, Capricor Therapeutics, Neurona Therapeutics, MiMedx Group and Ossio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell therapy for diabetes is developed from stem cells.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine for cardiovascular disorders is developed using cell-based platforms.
|
|
| domain | founded_year | HQ Location |
Cell-based therapies are developed for intractable neurological diseases.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Epibone
Frequently Asked Questions about EpiBone
When was EpiBone founded?
EpiBone was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is EpiBone located?
EpiBone is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Is EpiBone a funded company?
EpiBone is a funded company, having raised a total of $48.63M across 10 funding rounds to date. The company's 1st funding round was a Series B of $18.45M, raised on Jun 11, 2014.
What does EpiBone do?
Founded in 2013 and based in Brooklyn, United States, the company operates in the biotechnology sector focused on regenerative medicine. Custom autologous bone grafts are engineered through a bioreactor platform, where CT scan data is used to create anatomically shaped scaffolds. These scaffolds are seeded with stem cells from the patients own tissue and matured in a proprietary bioreactor system for bone preconditioning and development.
Who are the top competitors of EpiBone?
EpiBone's top competitors include Theradaptive, MiMedx Group and Neurona Therapeutics.
What products or services does EpiBone offer?
EpiBone offers Bioreactor and Personalized Bone Products.
Who are EpiBone's investors?
EpiBone has 8 investors. Key investors include HHS, Hackensack Meridian Health, EMV Capital, Plum Alley Investments, and EMV Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.